History 1 페이지
본문 바로가기
BOOKMAR
HOME
NEWS
SITEMAP
주메뉴입니다.
INTRODUCTION
Greetings from CEO
Vision&Mission
Core Value & Strategy
INNOVAC s talents
The Future
History
Organization Chart
Location
PRODUCTS
InnoMyco vaccine
InnoMyCirco vaccine
InnoCirco vaccine
Myco-α vaccine
InnoPED-α vaccine
R&D
R&D Pipeline
Core Technology of R&D
Partners
NOTICE
News
Recruitment
Q&A
KOR
ENG
INTRODUCTION
Global vaccine development company creating new value for our customers by applying a variety of innovative technologies
HOME
INTRODUCTION
History
INTRODUCTION
History
Greetings from CEO
Vision&Mission
Core Value & Strategy
INNOVAC s talents
The Future
History
Organization Chart
Location
History
2024
10
Signed strategic sales agreement with Virbac(a global animal pharmaceutical company)for INNOVAC' InnoMyco vaccine
10
CEO. Hahn Tae-wook received Prime Minister's Commendation from Ministry of Agricultural, Food&Rural Affairs
08
First Launch of InnoMyCirco Vaccine in Korea
03
Signed a business agreement with Kangwon National University's KNU IP Professional Human Resources Training Project Group
03
Licensed as an Animal Medicine Manufacturing Item for InnoMyCirco Vaccine
01
Selected as WIN-WIN HONORS by Ministry of SMEs and Startups
2023
12
Received the Encouragement Award as the Grand Prize for Gangwon Small and Medium Enterprises
11
Awarded Ministerial Award from Ministry of SMEs and Startups
10
Receieved the Grand prize of 2023 'Excellent Company IR Mart' from SME and Startup Agency and Kangwon National University
09
First Launch of InnoMyco Vaccine in Korea
08
First overseas export of Myco-α Vaccine to Vietnam
08
Licensed as 'New Excellent Technology(NET)'certification by The Ministry for Agricultural,Forestry and Food in Korea : InnoMyCirco Vaccine
05
Finally selected for the '23 Gangwon Bio Promising Company Growth Package Support Project'
02
Applied for an item permit for InnoMyCirco Vaccine
2022
12
Approval for designation as a testing agency for animal medicines
10
Licensed as an Animal Medicine Manufacturing Item for Inomyco Vaccine
05
Selected as 'the First Penguin' by KOREA Credit Guarantee Fund(KODIT)
05
Patent granted for swine MYCOPLASMA Vaccine
by Ministry of Science & Technology(Vietnam)
02
Approved for clinical trial plan(IND) of InnoMyCirco Vaccine
2021
12
Licensed as an Animal medicine item for Swine Mycoplasma Vaccine (Inno MHP Vaccine) in Vietnam
05
Certified as a Military Service Designated Company
01
Approved for domestic clinical trials of InnoMyco vaccine
2020
12
Selected as a development project for Zika virus vaccine
05
Selected as a research project for the start-up leap package
03
Authorized the permission to export the swine Mycoplasma vaccine
02
Applied for an item permit for the swine Mycoplasma vaccine in Vietnam
2019
12
Patent granted for Swine Mycoplasma bivalent vaccines(USA)
12
Patent application filed for Zika virus vaccine
09
Established an affiliated research institute
08
Receipt of Series A investment
08
Selected as a TIPS project by the Ministry of SMEs & Startups
08
Patent application filed for Swine Mycoplasma bivalent vaccine (USA)
04
Patent application filed for Porcine Circovirus vaccine
02
Receipt of Pre-series investment
2018
07
Registered as a Venture Company
07
Implementation of U-Tech
04
Patent granted for Swine Mycoplasma bivalent vaccines(Korea)
2017
08
Finalized a patent application for Swine Mycoplasma bivalent vaccines
2016
05
Company name changed to 'Innovac'
03
'Beeson Bio Lab' founded